Tuberculosis pp 281-293 | Cite as

Clinical Syndromes and Diagnosis of Nontuberculous (“Atypical”) Mycobacterial Infection

  • Henry YeagerJr.

Abstract

Bacteriologists knew for decades that there were “atypical,” tuberculosis-like organisms occasionally isolated from the body fluids of patients, but the conventional wisdom was that these organisms were saprophytic and not pathogenic for humans (1,2). It was only in the mid-1950’s, with the development of effective chemotherapy for Mycobacterium tuberculosis, and with more wide-spread culturing of biologic fluids with positive acid-fast smears, that researchers finally accepted that there were persons with tuberculosis-like disease from whom no other pathogens could be isolated (3,4).

Keywords

Dust Tuberculosis Bacillus Indomethacin Mycobacterium 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Branch A. A study of acid-fast organisms other than mammalian tubercle bacilli isolated from disease in man. Tubercle 1933;14:337–53.CrossRefGoogle Scholar
  2. 2.
    Pinner M. Atypical acid-fast organisms. Chro-mogenic acid-fast bacilli from human beings. Am Rev Tuberc 1935;32:363–74.Google Scholar
  3. 3.
    Buhler V, Pollak A. Human infection with atypical acid-fast organisms: Report of two cases with pathologic findings. Am J Clin Path 1954;23:363–74.Google Scholar
  4. 4.
    Timpe A, Runyon EH. The relationship of “atypical” acid-fast bacteria to human disease. A preliminary report. J Lab Clin Med 1954;44:202–9.PubMedGoogle Scholar
  5. 5.
    Wolinsky E. Non tuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979;119:107–59.PubMedGoogle Scholar
  6. 6.
    Wallace RJ Jr, O’Brien R, Glassroth J, et al. Diagnosis and treatment of disease caused by non-tuberculous mycobacteria. Am Rev Respir Dis 1990;142:940–53.Google Scholar
  7. 7.
    Runyon EH. Ten mycobacterial pathogens. Tubercle 1974;55:235–40.PubMedCrossRefGoogle Scholar
  8. 8.
    Chapman JC. The atypical mycobacteria and human mycobacteriosis. New York, Plenum Press, 1977, pp 17–31.Google Scholar
  9. 9.
    Good RC. Opportunistic pathogens in the genus Mycobacterium. Ann Rev Microbiol 1985;39:347–69.CrossRefGoogle Scholar
  10. 10.
    Wayne LG. The “atypical” mycobacteria. Recognition and disease association. CRC Crit Rev Microbiol 1985;12:185–222.CrossRefGoogle Scholar
  11. 11.
    Butler WR, Ahearn DG, Kilburn JO. High performance liquid chromatography of mycolic acids as a tool in the identification of Corynebacterium, Nocardia, Rhodococcus, and Mycobacterium species. J Clin Microbiol 1986;23:182–5.PubMedGoogle Scholar
  12. 12.
    Lazlo A, Siddiqi SH. Evaluation of a rapid radiometric differentiation test for the Mycobacterium tuberculosis-complex by selective inhibition with p-nitro-alpha-acetylamino-beta-hy-droxypropriophenone. J Clin Micro 1984;19: 694–8.Google Scholar
  13. 13.
    Shoemaker, SA, Fisher JH, Scoggin CH. Techniques of DNA hybridization to detect small numbers of mycobacteria with no cross-hybridization with non-mycobacterial respiratory organisms. Am Rev Respir Dis 1981;124:559–62.Google Scholar
  14. 14.
    Catanzaro A, Linzer B, Mulis K. PCR for the detection of Mycobacterium avium-intracellulare. Am Rev Respir Dis 1991;143 (Supp):Alll.Google Scholar
  15. 15.
    Eisenach KD, Sifford MD, Cave MD, et al. Detection of Mycobacterium tuberculosis in sputum samples using a polymerase chain reaction. Am Rev Respir Dis 1991;144:1160–1163.PubMedCrossRefGoogle Scholar
  16. 16.
    Edwards LB, Acquaviva FA, Livesay VT, et al. An atlas of sensitivity to tuberculin, PPD-B and histoplasmin in the United States. Am Rev Respir Dis 1969;99(Supp):l-13.Google Scholar
  17. 17.
    Ahn CH, Lowell JR, Onstad GD et al. A demographic study of disease due to Mycobacterium kansasii or Mycobacterium intracellulare-avium in Texas. Chest 1979;75:120–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Gruft H, Falkinham JO, Parker BC. Recent experience in the epidemiology of disease caused by atypical mycobacteria. Rev Infect Dis 1981;3:990–6.PubMedCrossRefGoogle Scholar
  19. 19.
    O’Brien RJ. The epidemiology of nontubercu-lous mycobacterial disease. Clin Chest Med 1989;10:407–418.PubMedGoogle Scholar
  20. 20.
    Wolinsky E. When is an infection disease? Rev Infect Dis 1981;3:1025–27.PubMedCrossRefGoogle Scholar
  21. 21.
    Wendt SL, George KL, Parker BC et al. Epidemiology of infection by nontuberculous mycobacteria. III. Isolation of potentially pathogenic mycobacteria from aerosols. Am Rev Respir Dis 1980;122:259–63.PubMedGoogle Scholar
  22. 22.
    Brooks RW, Parker BC, Gruft H et al. Epidemiology of infection by nontuberculous mycobacteria. V. Numbers in eastern United States soils and corrrelation with soil characteristics. Am Rev Respir Dis 1984;130:630–3.PubMedGoogle Scholar
  23. 23.
    Fry KL, Meissner PS, Falkinham JO III. Epidemiology of infection by nontuberculous mycobacteria. VI. Identification and use of epidemiologic markers for studies of Mycobacterium avium, M. intracellular, and M. scrofulaceum. Am Rev Respir Dis 1986;134:39–43.PubMedGoogle Scholar
  24. 24.
    Del Baccaro MA, Mendelman PM, Nolan C. Diagnostic usefulness of mycobacterial skin test antigens in childhood lymphadenitis. Pediatr Inf Dis J 1989;8:206–10.Google Scholar
  25. 25.
    Good RC, Snider DE. Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis 1982;146:829–33.PubMedCrossRefGoogle Scholar
  26. 26.
    O’Brien RJ, Geiter LJ, Snider DE. The epidemiology of nontuberculous mycobacterial disease in the United States.: results from a national survey. Am Rev Respir Dis 1987; 135:1007–14.PubMedGoogle Scholar
  27. 27.
    Levine B, Chaisson RE. Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection. Ann Intern Med 1991;114:861–8.PubMedGoogle Scholar
  28. 28.
    Horsburgh CR Jr. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. New Eng J Med 1991;324:1332–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Ahn CH, Lowell JR, Onstad GD et al. A demographic study of disease due to Mycobacterium kansasii or M. intracellulare-avium in Texas. Chest 1979;75:120–5.PubMedCrossRefGoogle Scholar
  30. 30.
    Costrini AM, Mahler DA, Gross WM et al. Clinical and radiographic features of nosocomial pulmonary disease due to Mycobacterium xenopi. Am Rev Respir Dis 1981;123:104–9.PubMedGoogle Scholar
  31. 31.
    Kiehn TE, Edwards FF, Brannon P et al. Infections caused by Mycobacterium avium complex in immunocompromised patients. Diagnosis by blood culture and fecal examination, antimicrobial sensitivity tests and morphological and seroagglutination characteristics. J Clin Micro 1985;21:168–73.Google Scholar
  32. 32.
    Ellner JJ, Goldberger MJ, Parenti DM. Mycobacterium avium infection and AIDS: A therapeutic dilemma. J Infect Dis 1991;163:1326–35.PubMedCrossRefGoogle Scholar
  33. 33.
    Gernez-Rieux C, Taquet A, Devulder B, et al. Experimental study of interactions between pneumoconiosis and mycobacterial infections. Ann NY Acad Sci 1972;200:106–26.PubMedCrossRefGoogle Scholar
  34. 34.
    Gangadharam PR, Pratt PF, Davidson PT. Experimental infections with Mycobacterium intracellular. Rev Infect Dis 1981;3:973–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Winter SM, Bernard EM, Gold JWM et al. Humoral response to disseminated infection by Mycobacterium avium-Mycobacterium intracellular in acquired immunodeficiency syndrome and hairy cell leukemia. J Infect Dis 1985;151:523–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Schnittman S, Lane HC, Witebsky FG, et al. Host defense against Mycobacterium aviom complex. J Clin Immunol 1988;8:234–43.PubMedCrossRefGoogle Scholar
  37. 37.
    Katz P, Yeager H Jr, Whalen G, et al. Natural killer cell-mediated lysis of Mycobacterium-avium complex-infected monocytes. J Clin Immunol 1990;10:71–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Harshan KV, Gangadharam PRJ. In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium in mice. Infect Immun 1991;59:2818–21.PubMedGoogle Scholar
  39. 39.
    Orme IM, Miller ES, Roberts AD, et al. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. J Immunol 1992; 148:189–96.PubMedGoogle Scholar
  40. 40.
    Smith PD, Quinn TC, Strober W, et al. Gastrointestinal infections in AIDS. Ann Intern Med 1992;116:63–77.PubMedGoogle Scholar
  41. 41.
    Crowle AJ, Cohn DL, Poche P. Defects in sera from acquired immunodeficiency syndrome (AIDS) patients and non-AIDS patients with Mycobacterium avium infection which decrease macrophage resistance to M avium. Infect Immun 1989;57:1445–51.PubMedGoogle Scholar
  42. 42.
    Teirstein AS, Damsker B, Kirschner PA, et al. Pulmonary infection with Mycobacterium avium-intracellulare. Diagnosis, clinical patterns, treatment. J Mt Sinai Hosp 1990;57:209–15.Google Scholar
  43. 43.
    Mason UG III, Greenberg LE, Yen SS, et al. Indomethacin-sensitive mononuclear cell dysfunction in “atypical” mycobacteriosis. Cell Immunol 1982;71:5465.CrossRefGoogle Scholar
  44. 44.
    Corpe RF, Stergus I. Is histopathology of chro-mogenic mycobacterial infection distinguishable from that caused by M. tuberculosis? Am Rev Respir Dis 1963;87:289–91.PubMedGoogle Scholar
  45. 45.
    Lagrange PH, Hurtrel B. Anergy and other immunologic perturbances in mycobacterial infections. In: Bendinelli M, Friedman H, eds. Mycobacterium tuberculosis. Interactions with the immune system. New York: Plenum Press, 1988: pp. 171–205.Google Scholar
  46. 46.
    Hayman J, McQueen A. The pathology of Mycobacterium ulcer ans infection. Pathology 1985;17:594–600.PubMedCrossRefGoogle Scholar
  47. 47.
    Reichert CM, O’Leary TJ, Levens DL, et al. Autopsy pathology in the acquired immune deficiency syndrome. Am J Path 1983;112:357–82.PubMedGoogle Scholar
  48. 48.
    Yeager H Jr, Raleigh JW. Pulmonary disease due to Mycobacterium intracellular. Am Rev Respir Dis 1973;108:547–52.PubMedGoogle Scholar
  49. 49.
    Rosensweig DY. “Atypical” mycobacterioses. Clin Chest Med 1980;1:273–84.Google Scholar
  50. 50.
    Davidson PT. The diagnosis and management of disease caused by M avium complex, M kansasii, and other mycobacteria. Clin Chest Med 1989;10:431–43.PubMedGoogle Scholar
  51. 51.
    Prince DS, Peterson DD, Steiner RM, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. New Eng J Med 1989;321:863–8.PubMedCrossRefGoogle Scholar
  52. 52.
    Iseman MD, Buschman DL, Ackerson LM. Pectus excavatum and scoliosis. Thoracic abnormalities associated with pulmonary disease caused by Mycobacterium avium complex. Am Rev Respir Dis 1991;144:914–16.PubMedCrossRefGoogle Scholar
  53. 53.
    Lillo M, Orrengo S, Cernoch P, et al. Pulmonary and disseminated infection due to Mycobacterium kansasii. Rev Infect Dis 1990;12:760–7.PubMedCrossRefGoogle Scholar
  54. 54.
    Christensen EE, Dietz GW, Ahn CH, et al. Radiographic manifestations of pulmonary Mycobacterium kansasii infections. Am J Roentgen 1978;131;985–93.Google Scholar
  55. 55.
    Christensen EE, Dietz GW, Ahn CH, et al. Pulmonary manifestations of Mycobacterium intracellulars. Am J Radiol 1979;133:59–66.Google Scholar
  56. 56.
    Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease. Am Rev Respir Dis 1991;143:1381–5.PubMedGoogle Scholar
  57. 57.
    Rosensweig DY, Schleuter DP. Spectrum of clinical disease in pulmonary infection with Mycobacterium avium-intracellulare. Rev Infect Dis 1981;3:1046–51.CrossRefGoogle Scholar
  58. 58.
    Francis PB, Jay SJ, Johanson WG Jr. The course of untreated Mycobacteriium kansasii disease. Am Rev Respir Dis 1975;111:477–87.PubMedGoogle Scholar
  59. 59.
    Wallace RJ Jr. The clinical presentations, diagnosis, and therapy of cutaneous and pulmonary infections due to the rapidly growing mycobacteria, M fortuitum and M chelonae. Clin Chest Med 1989;10:419–29.PubMedGoogle Scholar
  60. 60.
    Street ML, Umbert-Millet IJ, Roberts GD, et al. Nontuberculous mycobacterial infections of the skin. J Am Acad Dermat 1991;24:208–15.CrossRefGoogle Scholar
  61. 61.
    Philpott JA Jr, Woodborne AR, Philpott OS, et al. Swimming pool granuloma: A study of 290 cases. Arch Dermat 1963;88:158–62.Google Scholar
  62. 62.
    Anonymous. Mycobacterium haemophilum infections—New York City area, 1990–91. MMWR 1991;40:636–43.Google Scholar
  63. 63.
    Lincoln EM, Gilbert LA. Disease in children due to mycobacteria other than Mycobacterium tuberculosis . Am Rev Respir Dis 1972;105:683–714.PubMedGoogle Scholar
  64. 64.
    Lai KK, Stottmeier KD, Sherman IH, et al. Mycobacterial cervical lymphadenopathy. JAMA 1984;251:1286–8.PubMedCrossRefGoogle Scholar
  65. 65.
    Kelly DH, Weed LA, Lipscomb RP. Infection of tendon sheaths, bursae, joints and soft tissues by acid fast bacteria other than tubercle bacilli. J Bone Joint Surg 1963;45A:327–36.Google Scholar
  66. 66.
    Kelly PJ, Karlson AG, Weed LA, et al. Infection of synovial tissues by mycobacteria other than M tuberculosis. J Bone Joint Surg 1967;49A: 1521–30.Google Scholar
  67. 67.
    Marchevsky AM, Damsker B, Green S, et al. The clinicopathological spectrum of non-tuberculous mycobacterial osteoarticular infections. J Bone Joint Surg 1985;67A:925–9.Google Scholar
  68. 68.
    Messner RP. Arthritis due to mycobacteria, fungi, and parasites. In: McCarty DJ ed. Arthritis and Related Conditions. Philadelphia, Lea and Febiger, 1988, pp. 1925–37.Google Scholar
  69. 69.
    Robicsek F, Hoffman PC, Masters TN, et al. Rapidly growing nontuberculous mycobacteria: A new enemy of the cardiac surgeon. Ann Thor Surg 1988;46:703–10.CrossRefGoogle Scholar
  70. 70.
    Wallace RJ Jr, Musser JM, Hull SI, et al. Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery. J Infect Dis 1989;4:708–16.CrossRefGoogle Scholar
  71. 71.
    Schlossberg D, Aaron T. Aortitis caused by Mycobacterium fortuitum. Arch Int Med 1991; 151:1010–11.CrossRefGoogle Scholar
  72. 72.
    Clark R, Cardona L, Valainis G, et al. Genitourinary infections caused by mycobacteria other than Mycobacterium tuberculosis. Tubercle 1989;70:297–300.PubMedCrossRefGoogle Scholar
  73. 73.
    Bennett C, Vardiman J, Golomb H. Disseminated atypical mycobacterial infections in patients with hairy cell leukemia. Am J Med 1986;80:891–96.PubMedCrossRefGoogle Scholar
  74. 74.
    McKenzie R, Travis WD, Dolan SA, et al. The causes of death in patients with human immunodeficiency virus infection: a clinical and pathologic study with emphasis on the role of pulmonary disease. Medicine 1991;70:326–43.PubMedCrossRefGoogle Scholar
  75. 75.
    Jacobson MA, Hopewell PC, Yajko DM, et al. Natural history of disseminated Mycobacterium avium complex in AIDS. J Infect Dis 1991; 164:994–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Gold JWW. Mycobacterial infections in im-munosuppressed patients. Sem Resp Infections 1986;1:160–5.Google Scholar
  77. 77.
    Rouse DA, Morris SL, Karpas AB, et al. Production, characterization, and species specificity of monoclonal antibodies to Mycobacterium avium complex protein antigens. Infect. Immunity 1991;58:1445–9.Google Scholar

Copyright information

© Springer-Verlag New York, Inc. 1994

Authors and Affiliations

  • Henry YeagerJr.

There are no affiliations available

Personalised recommendations